research

Urban Health Making Cities Sustainable and Healthier for All

Urban health: making cities sustainable and healthier for all

The current Covid-19 pandemic draws attention to the need to integrate health equity into urban planning. It encourages behaviours that both protect the environment and promote health.

Andrea Renda, Futuristic Europe outline connectivity map with lines, stars, triangles, light particles framework

A scientist’s opinion : Interview with Prof. Andrea Renda about COVID-19 & GDPR

We speak with Andrea Renda, professor of Digital Innovation at the College of Europe in Bruges (Belgium). He is a Senior Research Fellow and Head of the CEPS Unit on Global Governance, Regulation, Innovation and the Digital Economy (GRID). How do you evaluate the current increased use of data (especially in non-EU countries) and its effectiveness ...

Innocenzo Genna; Futuristic Europe outline connectivity map with lines, stars, triangles, light particles framework

A scientist’s opinion : Interview with Innocenzo Genna about COVID-19 & GDPR

We speak with Innocenzo Genna, independent public affairs consultant advising in telecoms and Internet European regulation. He is also known via his professional blog RadioBruxellesLibera. How would you evaluate the current increased use of data (especially in non-EU countries) and its effectiveness in “stopping” the virus? Innocenzo Genna: I have read various news and reports ...

Futuristic Europe outline connectivity map with lines, stars, triangles, light particles framework

Which way for EU data governance during COVID-19?

Since the unprecedented outbreak of the COVID-19 virus, the use of data has extensively been discussed. What obstacles do scientists, public health officials and private companies face when processing datasets? And how much digital privacy can EU citizens afford in times of crisis?

Anna Odone, Futuristic Europe outline connectivity map with lines, stars, triangles, light particles framework

A scientist’s opinion : Interview with Prof. Anna Odone about COVID-19 & GDPR

We speak with Anna Odone, Associate Professor of Public Health at the Faculty of Medicine of the University Vita-Salute San Raffaele in Milan. As a consultant physician, responsible for the Unit of Clinical Epidemiology and Health Technology Assessment at San Raffaele Scientific Institute, she is the President of the Digital Health Section of the European ...

A scientist’s opinion: Interview with Professor Giovanni Rezza on tackling the Covid-19 pandemic

A scientist’s opinion : Interview with Professor Giovanni Rezza on tackling the Covid-19 pandemic

Tackling the Covid-19 pandemic, a scientist’s opinion We speak with Professor Giovanni Rezza, MD, Director of the Department of Infectious Diseases at the Istituto Superiore di Sanità, Roma, Italy about the EU’s announcement of funding for research to tackle Covid-19, and current efforts to develop vaccines and antiviral drugs. How prepared was the EU for ...

A scientist’s opinion: Interview with Professor Paul Digard on research efforts to develop treatments against Covid-19

A scientist’s opinion : Interview with Professor Paul Digard on research efforts to develop treatments against Covid-19

Research efforts to develop treatments against Covid-19 Professor Paul Digard, virologist at The Roslin Institute, University of Edinburgh, tells us about potential routes to Covid-19 treatment and the prospect of having to deal with the virus long-term. How soon do you think a vaccine against Covid-19 will be available? Paul Digard: I can’t see a ...

A scientist’s opinion : Interview with Aroon Hingorani about re-engineering pharmaceutical research

A scientist’s opinion : Interview with Aroon Hingorani about re-engineering pharmaceutical research

Interview with Aroon Hingorani, Professor of Genetic Epidemiology at University College London about Re-engineering pharmaceutical research. Could you speculate what you think are the biggest causes of drug failure? Aroon Hingorani: It is well recognised that the number one cause for drug failure is a lack of efficacy of the drug in the intended indication, ...

European Science-Media Hub
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.